Adjuvant treatment of resectable biliary tract cancer with cisplatin plus gemcitabine: A prospective single center phase II study.

Mednet Member

Medical Oncology · Moffitt Cancer Center

We would offer adjuvant chemotherapy to this patient based on data from the BILCAP study. Final results are still to be published in a peer reviewed journal. This study enrolled patients with biliary malignancies who were randomized to adjuvant capecitabine vs. observation following resection. 18% o...